GSK wins US approval for twice-yearly asthma drugG
Continue reading...

GSK wins US approval for twice-yearly asthma drug
GSK wins US approval for twice-yearly asthma drug
 The U.S. health regulator has approved GSK's (GSK.L), opens new tab add-on treatment for severe asthma, offering a less...




